Article content
Britain’s medicines regulator said on
Thursday it had approved AstraZeneca’s antibody-based
treatment to prevent COVID-19 in people whose immune response is
poor.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil
D’Silva)
financialpost.com